{"entity":{"type":"insider","cik":"0001682027","url":"/insider/0001682027","json_url":"/insider/0001682027.json","name":"Dylan-Hyde Tyler","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":10,"first":"2017-04-21","last":"2018-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Dylan-Hyde Tyler","source":"filing","n_filings":10,"first_seen":"2017-04-21","last_seen":"2018-01-18"}],"transactions":[{"id":6380941,"accession":"0000899243-18-001348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-001348","line_url":"/filing/0000899243-18-001348","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66000.0,"shares_display":"66,000","price_per_share":28.03417272727273,"price_display":"28.03","price_state":"stated","total_value":1850255.4,"total_display":"1,850,255.40","total_whole":"1,850,255","shares_owned_after":25204.0,"shares_owned_after_display":"25,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider","n_lines":3},{"id":6380912,"accession":"0000899243-18-000520","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-000520","line_url":"/filing/0000899243-18-000520","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":21.644736842105264,"price_display":"21.64","price_state":"stated","total_value":822500.0,"total_display":"822,500.00","total_whole":"822,500","shares_owned_after":70204.0,"shares_owned_after_display":"70,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider","n_lines":2},{"id":6176538,"accession":"0000899243-18-000074","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-000074","line_url":"/filing/0000899243-18-000074","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30300.0,"shares_display":"30,300","price_per_share":22.74108910891089,"price_display":"22.74","price_state":"stated","total_value":689055.0,"total_display":"689,055.00","total_whole":"689,055","shares_owned_after":100204.0,"shares_owned_after_display":"100,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-02","scope":"insider","n_lines":4},{"id":6176503,"accession":"0000899243-18-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-000074","line_url":"/filing/0000899243-18-000074#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":21.75,"price_display":"21.75","price_state":"stated","total_value":15225.0,"total_display":"15,225.00","total_whole":"15,225","shares_owned_after":115204.0,"shares_owned_after_display":"115,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2018-01-02","scope":"insider"},{"id":5310733,"accession":"0000899243-17-029619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-029619","line_url":"/filing/0000899243-17-029619#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.55,"price_display":"20.55","price_state":"stated","total_value":308250.0,"total_display":"308,250.00","total_whole":"308,250","shares_owned_after":115204.0,"shares_owned_after_display":"115,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":4392197,"accession":"0000899243-17-029163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-029163","line_url":"/filing/0000899243-17-029163#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.8997,"price_display":"18.90","price_state":"stated","total_value":283495.5,"total_display":"283,495.50","total_whole":"283,496","shares_owned_after":130204.0,"shares_owned_after_display":"130,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-19","scope":"insider"},{"id":4217438,"accession":"0000899243-17-019847","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-019847","line_url":"/filing/0000899243-17-019847#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1313.0,"shares_display":"1,313","price_per_share":18.5998,"price_display":"18.60","price_state":"stated","total_value":24421.5374,"total_display":"24,421.54","total_whole":"24,422","shares_owned_after":153204.0,"shares_owned_after_display":"153,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-08","filed_date":"2017-08-08","scope":"insider"},{"id":4217435,"accession":"0000899243-17-019847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-019847","line_url":"/filing/0000899243-17-019847#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13210.0,"shares_display":"13,210","price_per_share":18.5624,"price_display":"18.56","price_state":"stated","total_value":245209.304,"total_display":"245,209.30","total_whole":"245,209","shares_owned_after":154517.0,"shares_owned_after_display":"154,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-07","filed_date":"2017-08-08","scope":"insider"},{"id":4217432,"accession":"0000899243-17-019847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-019847","line_url":"/filing/0000899243-17-019847#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":477.0,"shares_display":"477","price_per_share":18.55,"price_display":"18.55","price_state":"stated","total_value":8848.35,"total_display":"8,848.35","total_whole":"8,848","shares_owned_after":167727.0,"shares_owned_after_display":"167,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-08","scope":"insider"},{"id":4886334,"accession":"0000899243-17-011672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-011672","line_url":"/filing/0000899243-17-011672#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1852.0,"shares_display":"1,852","price_per_share":16.6055,"price_display":"16.61","price_state":"stated","total_value":30753.386,"total_display":"30,753.39","total_whole":"30,753","shares_owned_after":168204.0,"shares_owned_after_display":"168,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider"},{"id":4690812,"accession":"0000899243-17-011230","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-011230","line_url":"/filing/0000899243-17-011230#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4912.0,"shares_display":"4,912","price_per_share":16.6201,"price_display":"16.62","price_state":"stated","total_value":81637.9312,"total_display":"81,637.93","total_whole":"81,638","shares_owned_after":170056.0,"shares_owned_after_display":"170,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-28","filed_date":"2017-04-28","scope":"insider"},{"id":4690806,"accession":"0000899243-17-011230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-011230","line_url":"/filing/0000899243-17-011230#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13527.0,"shares_display":"13,527","price_per_share":16.8403,"price_display":"16.84","price_state":"stated","total_value":227798.7381,"total_display":"227,798.74","total_whole":"227,799","shares_owned_after":174968.0,"shares_owned_after_display":"174,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-28","scope":"insider"},{"id":4690801,"accession":"0000899243-17-011230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-011230","line_url":"/filing/0000899243-17-011230#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":16.7627,"price_display":"16.76","price_state":"stated","total_value":53640.64,"total_display":"53,640.64","total_whole":"53,641","shares_owned_after":180495.0,"shares_owned_after_display":"180,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-28","scope":"insider"},{"id":4391023,"accession":"0000899243-17-010883","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-010883","line_url":"/filing/0000899243-17-010883#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":16.8729,"price_display":"16.87","price_state":"stated","total_value":80989.92,"total_display":"80,989.92","total_whole":"80,990","shares_owned_after":183695.0,"shares_owned_after_display":"183,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-25","scope":"insider"},{"id":4391019,"accession":"0000899243-17-010883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-010883","line_url":"/filing/0000899243-17-010883#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3522.0,"shares_display":"3,522","price_per_share":16.4387,"price_display":"16.44","price_state":"stated","total_value":57897.1014,"total_display":"57,897.10","total_whole":"57,897","shares_owned_after":188495.0,"shares_owned_after_display":"188,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-25","scope":"insider"},{"id":4391014,"accession":"0000899243-17-010883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-010883","line_url":"/filing/0000899243-17-010883#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3010.0,"shares_display":"3,010","price_per_share":17.0174,"price_display":"17.02","price_state":"stated","total_value":51222.374,"total_display":"51,222.37","total_whole":"51,222","shares_owned_after":192017.0,"shares_owned_after_display":"192,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-21","filed_date":"2017-04-25","scope":"insider"},{"id":5009511,"accession":"0000899243-17-010730","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-010730","line_url":"/filing/0000899243-17-010730#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2937.0,"shares_display":"2,937","price_per_share":17.3732,"price_display":"17.37","price_state":"stated","total_value":51025.0884,"total_display":"51,025.09","total_whole":"51,025","shares_owned_after":195027.0,"shares_owned_after_display":"195,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-20","filed_date":"2017-04-21","scope":"insider"},{"id":5009507,"accession":"0000899243-17-010730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-010730","line_url":"/filing/0000899243-17-010730","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682027","owner_name":"Dylan-Hyde Tyler","owner_display_name":"Dylan-Hyde Tyler","owner_url":"/insider/0001682027","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7240.0,"shares_display":"7,240","price_per_share":17.840470441988952,"price_display":"17.84","price_state":"stated","total_value":129165.006,"total_display":"129,165.01","total_whole":"129,165","shares_owned_after":200274.0,"shares_owned_after_display":"200,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-21","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (Chief Legal Officer)","n_filings":10,"first_seen":"2017-04-21","last_seen":"2018-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682027","retrieved_at":"2026-08-26T06:58:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}